Journal of Korean Neurosurgical Society

The Korean Neurosurgical Society (대한신경외과학회)
권호 표지
DOI QR코드

DOI QR Code

Incidence and Risk Factors of Infection Caused by Vancomycin-Resistant Enterococcus Colonization in Neurosurgical Intensive Care Unit Patients

  • Se, Young-Bem (Departments of Neurosurgery, Hanyang University Medical Center) ;
  • Chun, Hyoung-Joon (Departments of Neurosurgery, Hanyang University Medical Center) ;
  • Yi, Hyeong-Joong (Departments of Neurosurgery, Hanyang University Medical Center) ;
  • Kim, Dong-Won (Anesthesiology and Pain Medicine, Hanyang University Medical Center) ;
  • Ko, Yong (Departments of Neurosurgery, Hanyang University Medical Center) ;
  • Oh, Suck-Jun (Departments of Neurosurgery, Hanyang University Medical Center)
  • Published : 2009.08.28
Download PDF
⟨ Previous Next ⟩

Abstract

Objective: This study was aimed to identify the incidence and risk factors of vancomycin-resistant enterococcus (VRE) colonization in neurosurgical practice of field, with particular attention to intensive care unit (ICU). Methods: This retrospective study was carried out on the Neurosurgical ICU (NICU), during the period from January. 2005 to December. 2007, in 414 consecutive patients who had been admitted to the NICU. Demographics and known risk factors were retrieved and assessed by statistical methods. Results: A total of 52 patients had VRE colonization among 414 patients enrolled, with an overall prevalence rate of 6.1%. E. faecium was the most frequently isolated pathogen, and 92.3% of all VRE were isolated from urine specimen. Active infection was noticed only in 2 patients with bacteremia and meningitis. Relative antibiotic agents were third-generation cephalosporin in 40%, and vancomycin in 23%, and multiple antibiotic usages were also identified in 13% of all cases. Multivariate analyses showed Glasgow coma scale (GCS) score less than 8, placement of Foley catheter longer than 2 weeks, ICU stay over 2 weeks and presence of nearby VRE-positive patients had a significantly independent association with VRE infection. Conclusion: When managing the high-risk patients being prone to be infected VRE in the NICU, extreme caution should be paid upon. Because prevention and outbreak control is of ultimate importance, clinicians should be alert the possibility of impending colonization and infection by all means available. The most crucial interventions are careful hand washing, strict glove handling, meticulous and active screening, and complete segregation.

Keywords

References

  1. Archibald L, Phillips L, Monnet D, McGowan JE Jr, Tenover F,Gaynes R : Antimicrobial resistance in isolates from inpatients andoutpatients in the United States : increasing importance of the intensivecare unit. Clin Infect Dis 24 : 211-215, 1997 https://doi.org/10.1093/clinids/24.2.211
  2. Boyce JM : Vancomycin-resistant enterococcus. Detection, epidemiology, and control measures. Infect Dis Clin North Am 11 : 367-384, 1997 https://doi.org/10.1016/S0891-5520(05)70361-5
  3. Byers KE, Anglim AM, Anneski CJ, Germanson TP, Gold HS,Durbin LJ, et al. : A hospital epidemic of vancomycin-resistant Enterococcus: risk factors and control. Infect Control Hosp Epidemiol 22 :140-147, 2001 https://doi.org/10.1086/501880
  4. Carmeli Y, Eliopoulos GM, Samore MH : Antecedent treatmentwith different antibiotic agents as a risk factor for vancomycin-resistantEnterococcus. Emerg Infect Dis 8 : 802-807, 2002 https://doi.org/10.3201/eid0808.010418
  5. Donskey CJ, Chowdhry TK, Hecker MT, Hoyen CK, HanrahanJA, Hujer AM, et al. : Effect of antibiotic therapy on the density ofvancomycin-resistant enterococci in the stool of colonized patients. NEngl J Med 343 : 1925-1932, 2000 https://doi.org/10.1056/NEJM200012283432604
  6. Edmond MB, Ober JF, Weinbaum DL, Pfaller MA, Hwang T,Sanford MD, et al. : Vancomycin-resistant Enterococcus faeciumbacteremia : risk factors for infection. Clin Infect Dis 20 : 1126-1133,1995 https://doi.org/10.1093/clinids/20.5.1126
  7. Furtado GH, Mendes RE, Pignatari AC, Wey SB, Medeiros EA :Risk factors for vancomycin-resistant Enterococcus faecalis bacteremiain hospitalized patients : an analysis of two case-control studies. Am JInfect Control 34 : 447-451, 2006 https://doi.org/10.1016/j.ajic.2005.08.015
  8. Gold HS : Vancomycin-resistant enterococci : mechanisms and clinical observations. Clin Infect Dis 33 : 210-219, 2001 https://doi.org/10.1086/321815
  9. Hendrix CW, Hammond JM, Swoboda SM, Merz WG, HarringtonSM, Perl TM, et al. : Surveillance strategies and impact of vancomycinresistantenterococcal colonization and infection in critically ill patients.Ann Surg 233 : 259-265, 2001 https://doi.org/10.1097/00000658-200102000-00016
  10. Lancaster AD : Draft guideline published on preventing the spread ofVRE infections. Hospital Infection Control Practices Advisory Committee.Asepsis 16 : 19-22, 1994
  11. Lautenbach E, Bilker WB, Brennan PJ : Enterococcal bacteremia :risk factors for vancomycin resistance and predictors of mortality.Infect Control Hosp Epidemiol 20 : 318-323, 1999 https://doi.org/10.1086/501624
  12. MacIntyre CR, Empson M, Boardman C, Sindhusake D, Lokan J,Brown GV : Risk factors for colonization with vancomycin-resistantenterococci in a Melbourne hospital. Infect Control Hosp Epidemiol22 : 624-629, 2001 https://doi.org/10.1086/501833
  13. Mainous MR, Lipsett PA, O'Brien M : Enterococcal bacteremia inthe surgical intensive care unit. Does vancomycin resistance affectmortality? The Johns Hopkins SICU Study Group. Arch Surg 132 :76-81, 1997 https://doi.org/10.1001/archsurg.1997.01430250078017
  14. Matar MJ, Tarrand J, Raad I, Rolston KV : Colonization and infectionwith vancomycin-resistant Enterococcus among patients with cancer.Am J Infect Control 34 : 534-536, 2006 https://doi.org/10.1016/j.ajic.2006.04.205
  15. Moellering RC Jr : Vancomycin-resistant enterococci. Clin InfectDis 26 : 1196-1199, 1998 https://doi.org/10.1086/520283
  16. Montecalvo MA, Shay DK, Gedris C, Petrullo C, Uman J, RodneyK, et al. : A semiquantitative analysis of the fecal flora of patients withvancomycin-resistant enterococci : colonized patients pose an infectioncontrol risk. Clin Infect Dis 25 : 929-930, 1997 https://doi.org/10.1086/597643
  17. Mutnick AH, Biedenbach DJ, Jones RN : Geographic variations andtrends in antimicrobial resistance among Enterococcus faecalis andEnterococcus faecium in the SENTRY Antimicrobial SurveillanceProgram (1997-2000). Diagn Microbiol Infect Dis 46 : 63-68, 2003 https://doi.org/10.1016/S0732-8893(03)00012-9
  18. Nam JR, Kim MS, Lee CH, Whang DH : Linezolid treatment forosteomyelitis due to Staphylococcus epidermidis with reduced vancomycinsusceptibility. J Korean Neurosurg Soc 43 : 307-310, 2008 https://doi.org/10.3340/jkns.2008.43.6.307
  19. Tacconelli E, Cataldo MA : Vancomycin-resistant enterococci (VRE) :transmission and control. Int J Antimicrob Agents 31 : 99-106, 2008 https://doi.org/10.1016/j.ijantimicag.2007.08.026
  20. Taylor ME, Oppenheim BA, Chadwick PR, Weston D, PalepouMF, Woodford N, et al. : Detection of glycopeptide-resistant enterococciin routine diagnostic faeces specimens. J Hosp Infect 43 : 25-32,1999 https://doi.org/10.1053/jhin.1999.0630
  21. Tokars JI, Satake S, Rimland D, Carson L, Miller ER, Killum E, et al. :The prevalence of colonization with vancomycin-resistant Enterococcusat a Veterans' Affairs institution. Infect Control Hosp Epidemiol20 : 171-175, 1999 https://doi.org/10.1086/501606
  22. van den Braak N, Ott A, van Belkum A, Kluytmans JA, KoelemanJG, Spanjaard L, et al. : Prevalence and determinants of fecal colonizationwith vancomycin-resistant enterococcus in hospitalized patientsin The Netherlands. Infect Control Hosp Epidemiol 21 : 520-524,2000 https://doi.org/10.1086/501797
  23. Weinstein JW, Roe M, Towns M, Sanders L, Thorpe JJ, Corey GR,et al. : Resistant enterococci : a prospective study of prevalence, incidence,and factors associated with colonization in a university hospital.Infect Control Hosp Epidemiol 17 : 36-41, 1996 https://doi.org/10.1086/647186

Cited by

  1. Treatment of Resistant Enterococcal Urinary Tract Infections vol.12, pp.6, 2009, https://doi.org/10.1007/s11908-010-0138-8
  2. Vancomycin Resistant Enterococci in Neonatal ICU- A Rising Menace vol.77, pp.12, 2010, https://doi.org/10.1007/s12098-010-0243-6
  3. Incidence of and Risk Factors for Infection or Colonization of Vancomycin-Resistant Enterococci in Patients in the Intensive Care Unit vol.7, pp.10, 2009, https://doi.org/10.1371/journal.pone.0047297
  4. Management of Antimicrobial Use in the Intensive Care Unit : vol.72, pp.4, 2009, https://doi.org/10.2165/11599520-000000000-00000
  5. Vancomycin-resistant enterococcus outbreak in a pediatric intensive care unit: report of successful interventions for control and prevention vol.45, pp.2, 2012, https://doi.org/10.1590/s0100-879x2012007500005
  6. Evaluation of Compliance in Control and Prevention Study of Vancomycin Resistant Enterococcus Outbreak vol.2013, pp.None, 2009, https://doi.org/10.1155/2013/252469
  7. Healthcare-associated vancomycin resistant Enterococcus faecium infections in the Mansoura University Hospitals intensive care units, Egypt vol.46, pp.3, 2009, https://doi.org/10.1590/s1517-838246320140403
  8. The direct and indirect effects of vancomycin-resistant enterococci colonization in liver transplant candidates and recipients vol.17, pp.5, 2019, https://doi.org/10.1080/14787210.2019.1607297
  9. Epidemiology of Vancomycin-Resistant Enterococcus faecium and Enterococcus faecalis Colonization in Nursing Facilities vol.7, pp.1, 2009, https://doi.org/10.1093/ofid/ofz553
  10. Impact of Inappropriate Antibiotic Therapy in Vancomycin-Resistant Enterococcus Bacteremia vol.28, pp.4, 2021, https://doi.org/10.1097/mjt.0000000000001127
  11. Risk factors for development of vancomycin-resistant enterococcal bacteremia among VRE colonizers : A retrospective case control study vol.133, pp.9, 2009, https://doi.org/10.1007/s00508-020-01733-7